Skip to main content

TheraMod™ Medical Device Manufacturer Malaysia

TheraMod Rehabilitation Device Portfolio

The TheraMod rehabilitation device portfolio includes RxDecom®, Spinercise®, and FD-3000™ across spinal decompression, movement rehabilitation, and flexion-distraction equipment categories.

This page focuses specifically on TheraMod’s rehabilitation devices, their equipment categories, intended rehabilitation environments, distributor relevance, manufacturing pathway, and investor review potential.

Unlike the homepage, this page is centered on the company’s current rehabilitation equipment portfolio rather than the broader company overview.

TheraMod states that it is registered with Malaysia’s Medical Device Authority, holds a Malaysian medical device manufacturing licence, and operates under an ISO 13485-certified quality management system certified by TÜV. Licence numbers, registration details, and certificate references should be displayed or linked where available.

Key Takeaways About the Device Portfolio

Area

Summary

Portfolio

RxDecom®, Spinercise®, FD-3000™

Equipment categories

Spinal decompression, movement rehabilitation, flexion-distraction

Intended environments

Trained rehabilitation and clinical settings

Buyer relevance

Clinics, distributors, investors

Manufacturing direction

Malaysia-based rehabilitation equipment pathway

Growth focus

Manufacturing, distributors, service systems, Asia expansion

RxDecom® Spinal Decompression Machine

RxDecom® is TheraMod’s spinal decompression machine developed for rehabilitation environments where guided workflow, positioning, load measurement, touchscreen control, and table access are important.

The device includes:

  • servo-controlled movement,
  • PLC and sensor systems,
  • load measurement,
  • touchscreen workflow,
  • split-table design,
  • adjustable tower positioning,
  • high-low table access.

RxDecom® supports TheraMod’s spinal decompression equipment category within the wider rehabilitation device portfolio.

Spinercise® Rehabilitation Device

Spinercise® is TheraMod’s movement rehabilitation device developed for guided rehabilitation movement and structured musculoskeletal rehabilitation workflows.

The device adds a movement-focused rehabilitation category to the portfolio and expands the company beyond decompression and table-assisted equipment.

Spinercise® is relevant to clinics, rehabilitation groups, distributors, and investors reviewing rehabilitation equipment categories.

FD-3000™ Flexion-Distraction Device

FD-3000™ is TheraMod’s flexion-distraction rehabilitation device developed for table-assisted rehabilitation environments.

The device includes:

  • motorized table movement,
  • cushioned surface structure,
  • adjustable headpiece,
  • stationary thoracolumbar section,
  • moveable pelvic section.

FD-3000™ supports the company’s flexion-distraction rehabilitation equipment category within the broader device portfolio.

Why the Rehabilitation Device Portfolio Matters

The portfolio structure matters because each device supports a different rehabilitation equipment category.

Together, RxDecom®, Spinercise®, and FD-3000™ support:

  • manufacturing growth,
  • service planning,
  • distributor onboarding,
  • technical training,
  • documentation systems,
  • regulatory preparation,
  • selected Asia market development.

For investors and distributors, the portfolio demonstrates broader rehabilitation equipment positioning rather than dependence on a single product category.

Rehabilitation Device Comparison

Device

Category

Main Equipment Focus

RxDecom®

Spinal decompression machine

Guided positioning, load measurement, touchscreen workflow

Spinercise®

Movement rehabilitation device

Guided movement and rehabilitation workflow

FD-3000™

Flexion-distraction rehabilitation device

Table-assisted positioning and rehabilitation setup

Distributor and Investor Relevance

The rehabilitation device portfolio supports TheraMod’s wider manufacturing and market-development direction.

The next stage includes:

  • manufacturing growth,
  • distributor onboarding,
  • servicing systems,
  • technical documentation,
  • professional training,
  • product-line expansion,
  • regional market preparation.

Investors may review the portfolio through manufacturing pathway, equipment categories, distributor readiness, and long-term commercial structure.

Distributors may review the portfolio through service needs, training requirements, documentation systems, and local market fit.

Frequently Asked Questions on Theramod Devices

What is the TheraMod rehabilitation device portfolio?

The portfolio includes RxDecom®, Spinercise®, and FD-3000™ across spinal decompression, movement rehabilitation, and flexion-distraction equipment categories.

What is RxDecom®?

RxDecom® is TheraMod’s spinal decompression machine.

What is Spinercise®?

Spinercise® is TheraMod’s movement rehabilitation device.

What is FD-3000™?

FD-3000™ is TheraMod’s flexion-distraction rehabilitation device

Are the devices intended for consumer use?

No. The devices are intended for trained rehabilitation and clinical environments.

Why is the rehabilitation device portfolio important?

The portfolio gives TheraMod multiple rehabilitation equipment categories that support manufacturing growth, distributor onboarding, technical training, and future market development.

Page Information

This TheraMod Rehabilitation Device Portfolio page was authored by Theramod’s founder Yama Zafer, D.C; read his bio here. It was last updated on May 20, 2026 to reflect TheraMod’s rehabilitation equipment categories, current device portfolio, distributor pathway, investor information, and Malaysia-based manufacturing direction.

Summary of TheraMod Devices Page

The TheraMod rehabilitation device portfolio includes RxDecom®, Spinercise®, and FD-3000™ across spinal decompression, movement rehabilitation, and flexion-distraction equipment categories.

The portfolio supports TheraMod’s wider rehabilitation equipment direction through manufacturing growth, service systems, distributor onboarding, training pathways, and selected Asia market development.

Together, the devices create a stronger commercial structure for clinics, rehabilitation groups, distributors, investors, and the long-term growth of the TheraMod rehabilitation device portfolio.